EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment failure in invasive aspergillosis due to poor tissue penetration by antifungal agents



Treatment failure in invasive aspergillosis due to poor tissue penetration by antifungal agents



Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 376




(PDF 0-2 workdays service: $29.90)

Accession: 035980155

Download citation: RISBibTeXText



Related references

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. Journal of Infection 53(5): 337-349, 2006

Local instillation of antifungal agents via fiberoptic bronchoscope for the treatment of invasive pulmonary Aspergillosis and aspergilloma. Annals of Hematology 77(SUPPL 2): S199, 1998

Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B. Journal of Antimicrobial ChemoTherapy 52(5): 873-876, 2003

Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure. Current Opinion in Investigational Drugs 5(8): 873-878, 2004

Investigation of treatment failure in invasive aspergillosis by testing the susceptibility of deep tissue isolates. British Journal of Haematology 113(Supplement 1): 51, 2001

Two cases of invasive pulmonary aspergillosis successfully treated with combination of antifungal agents. Nihon Kokyuki Gakkai Zasshi 47(10): 912-917, 2009

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrobial Agents and ChemoTherapy 44(12): 3381-3388, 2000

Tissue penetration of antifungal agents. Clinical Microbiology Reviews 27(1): 68-88, 2014

Aspergillus species and invasive aspergillosis mycology, pathogenesis, laboratory diagnosis, resistance of antifungal agents and susceptibility tests. Cerrahpasa Tip Dergisi 34(3): 140-157, July, 2003

Caspofungin: an echinocandin antifungal for the treatment of invasive aspergillosis. Formulary Cleveland 36(6): 427-436, 2001

Curative antifungal treatment of invasive pulmonary aspergillosis. Revue de Pneumologie Clinique 51(4): 228-231, 1995

Update of the multicenter noncomparative study of caspofungin in adults with invasive aspergillosis refractory or intolerant to other antifungal agents Analysis of 90 patients. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 388, 2002

Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. Journal of Clinical Pathology 65(1): 83-86, 2012

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Reviews of Infectious Diseases 12(6): 1147-1201, 1990

Combination antifungal treatment of pseudomembranous tracheobronchial invasive aspergillosis: a case report. Intensive Care Medicine 35(9): 1641-1643, 2009